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Outﬂow tractDiGeorge syndrome (DGS), characterized genetically by a deletion within chromosome 22q11.2, is associated
with a constellation of congenital heart defects. DiGeorge critical region 8 (Dgcr8), a gene that maps to the
common deletion region of DGS, encodes a double stranded RNA-binding protein that is essential for
miRNA biogenesis. To address the potential contribution of Dgcr8 insufﬁciency to cardiovascular develop-
ment, we have inactivated Dgcr8 in cardiac neural crest cells (cNCCs). Dgcr8 mutants displayed a wide spec-
trum of malformations, including persistent truncus arteriosus (PTA) and ventricular septal defect (VSD).
Interestingly, Dgcr8-null cNCCs that properly migrated into the cardiac outﬂow tract (OFT), proliferate nor-
mally and differentiate into vascular smooth muscle cells. However, loss of Dgcr8 causes a signiﬁcant portion
of the cNCCs to undergo apoptosis, causing a decrease in the pool of progenitors required for OFT remodeling.
Our data uncover a new role of Dgcr8 in cardiovascular morphogenesis, plausibly as part of transmission
mechanism for FGF-dependent survival cue for migrating cNCCs.
© 2011 Elsevier Inc. All rights reserved.Introduction
The genetic etiology of DiGeorge syndrome (DGS) involves a
3 Mbp microdeletion of the DiGeorge critical region (DGCR) on
human chromosome 22q11.2, thus it is also known as del22q11.2
syndrome. Cardiovascular defects observed in DGS, such as inter-
rupted aortic arch and ventricular septal defect (VSD) are also ob-
served in several mouse experimental models, in which the
expression of genes annotated to the microdeletion 22q11.2 was per-
turbed (Lindsay, 2001). However, recapitulation of the full-blown
human phenotype, including persistent truncus arteriosus (PTA) re-
quires homozygous deletion of 22q11.2 genes, such as Tbx1, suggest-
ing that other genes potentially contribute to DGS pathogenesis.
Indeed, many other mouse models provided important genetic in-
sights into the development of the cardiovascular system and its asso-
ciated diseases, including Crkl, TGFbr2, ERK1/2 and Shp2 (Guris et al.,
2001; Nakamura et al., 2009; Newbern et al., 2008; Wurdak et al.,
2005). Many of these experimental models focus on the cardiac neu-
ral crest cells (cNCCs), a unique subset of cells that migrate from the
dorsal aspect of the neural tube to remodel the pharyngeal arch arter-
ies (PAAs) and the septation of the cardiac outﬂow tract (OFT) into
two individual vessels: the pulmonary trunk and ascending aorta
(Hutson and Kirby, 2007). Thus, neural crest (NC)-speciﬁc knockout
models have proved useful in unraveling facets of the molecular net-
work governing OFT development and in addition provided tools toGenetics, 1314 Meyer Building,
0, Israel. Fax: +972 89344108.
ornstein).
rights reserved.study genes that hold different dosage threshold between the
mouse and the human cardiovascular systems (High et al., 2007;
Lepore et al., 2006; Vallejo-Illarramendi et al., 2009).
microRNAs (miRNAs) have emerged as central regulators of NC and
cardiovascular development (Cordes et al., 2009; Small and Olson,
2011; Xin et al., 2009). The maturation of most miRNAs is governed
by themicroprocessor complex, composed of the RNase III-like enzyme
DROSHA and the RNA-binding protein, DGCR8 (Seitz and Zamore,
2006). As suggested by its name, Dgcr8 is mapped within the 22q11.2
DGCR locus (and the syntenic region onmouse chromosome 16), mak-
ing it a potentially important component in the pathogenesis of DGS
(Shiohama et al., 2003). Furthermore, disruption of Dgcr8 results in be-
havioral and neuronal deﬁcits characteristic of DGS (Schoﬁeld et al.,
2011; Stark et al., 2008). Therefore, we sought to analyze the potential
role of Dgcr8 in cardiovascular development. Here, we describe con-
genital heart abnormalities that result from genetic inactivation of a
Dgcr8 conditional allele in neural crest cells (NCCs).
Materials and methods
Mouse genetics
Dgcr8 conditional allele (Wang et al., 2007) was crossed to a trans-
genic Cre line under the control of the Wnt1 promoter (a gift from
Andrew McMahon). To generate Dgcr8 conditional knockout embry-
os, Wnt1-cre;Dgcr8loxp/+ males were crossed with Dgcr8loxp/loxp fe-
males. R26R-lacZ or R26R-YFP reporter lines, generously shared by
P. Soriano and F. Constantini, respectively, were crossed into the
Dgcr8loxp/loxp females for genetic fate tracing.
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India ink was injected into the embryo left ventricle using a pulled
capillary tube. Injected embryos were subsequently ﬁxed in 4% PFA
overnight, dehydrated by graded methanol washes and cleared in
benzyl benzoate: benzyl alcohol (1:1).
Histology, immunochemistry and proliferation assays
Embryos were collected at stages of interest, rinsed in PBS, ﬁxed
overnight in 4% buffered paraformaldehyde at 4 °C, dehydrated through
a series of ethanol baths and embedded in Paraplast Plus (McCormick
Scientiﬁc). Parafﬁn sectionswere subjected to hematoxylin-Eosin stain-
ing or to immunoﬂuorescent analysis: Following rehydration, slides
were incubated in 10 mmol/L sodium citrate buffer pH6.0 on a 2100 Re-
triever (PickCell Laboratories) for a period of 3 h. Slides were then
washed in DDW, PBS and 0.1% Tween (Sigma) and blocked with CAS-
Block (Invitrogen) for 10 min at room temperature. Primary antibodies
in CAS-Block were incubated overnight at 4 °C: DGCR8 (10996-1-AP,
1:100 dilution, Proteintech), GFP (ab6658, 1:300, Abcam), Smooth
muscle α-actin (A 2547, 1:400, DAKO), cleaved Caspase-3 (9661,
1:300, Cell Signaling Technology). For proliferation assay, 1 h after in-
jection of BrdU at 100 μg/g body weight (Sigma), embryos were har-
vested and ﬁxed in 4% paraformaldehyde. Detection of BrdU-labeled
cells was performed by using an anti-BrdU antibody (RPN202, 1:300,
GE Healthcare). Cyanine conjugated anti-rabbit, anti-mouse or anti-
goat secondary antibodies (1:100, ImmunoResearch Laboratories)
were added in CAS-Block for 1 h at room temperature. 4′,6-Diami-
dino-2-phenylindole dihydrochloride (DAPI) was added for 5 min be-
fore slides were mounted with Immu-mount (Thermo Scientiﬁc).A
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B
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Fig. 1. Severe cardiovascular malformations observed in Dgcr8 mutants. Sagittal aortic ar
Dgcr8loxp/loxp;R26R-YFP mutants (B, n=4) stained for YFP (green) and DGCR8 (red). Mag
Wnt1-cre;Dgcr8loxp/loxp mutants (D–E, n=11) and respective schemes of the great vessels
n=11/11), while additional abnormalities included interrupted aortic arch type B (IAA; E′
vical aortic arch (Cx-AA; D′ n=2/11). RSA, right subclavian artery; RCC, right common carot
arch; Ao, aorta; DA, ductus arteriosus. Anterior (top) view of E18.5 OFT, divided into pulmon
Wnt1-cre;Dgcr8loxp/loxp (G). H&E staining of representative E18.5 frontal heart sections from
with persistent truncus arteriosus (PTA) and ventricular septal defect (VSD). Ao, aorta; PA
thymus (J, n=4) and Wnt1-cre;Dgcr8loxp/loxp thymus that is malformed and ectopically pos
lobe; Tr, trachea.Fluorescent images were captured with a Nikon 90i mounted with
Nikon D5-SM camera or a Zeiss LSM510 Laser Scanning confocal mi-
croscopy system.
Whole mount RNA in situ hybridization
Embryos were harvested and ﬁxed in 4% paraformaldehyde over-
night at 4 °C and dehydrated in gradedmethanols. DIG-labeled antisense
RNA probes for Crabp1 and Ap2-alpha were transcribed in vitro (Roche
Applied Science) following manufacturer's instructions.
Whole mount β-galactosidase staining
Embryos were ﬁxed in fresh 4% paraformaldehyde at 4 °C for
30 min, thoroughly washed with PBS, supplemented with 0.02% NP-
40 (Sigma) and developed in 20 mmol/L potassium ferricyanide,
20 mmol/L potassium ferrocyanide, 2 mmol/L magnesium chloride
and 0.4 mg/mL X-gal substrate in PBS, 0.02% NP-40, at 37 °C for 4 h.
Some embryos were further parafﬁn embedded and sectioned.
Results
Deletion of Dgcr8 in NCCs leads to severe cardiovascular defects
cNCCs remodel the PAAs and enable septation of the cardiac OFT
into the pulmonary artery and the aorta (Hutson and Kirby, 2007).
To assess Dgcr8 requirement in PAAs and OFT development, we gen-
eratedWnt1-cre;Dgcr8loxp/loxp mice by crossing a Dgcr8 conditional al-
lele (Wang et al., 2007) onto a Cre transgene that is driven by the
Wnt1 promoter. NC-speciﬁc Cre activity resulted in loss of DGCR8F G
H I
J K
ch sections of E10.5 Wnt1-cre;Dgcr8loxp/+;R26R-YFP controls (A, n=3) and Wnt1-cre;
niﬁed view in insets. (C–E) Gross thorax anatomy of E17.5 controls (C, n=10) and
(C′–E′). All Wnt1-cre;Dgcr8loxp/loxp displayed persistent truncus arteriosus (PTA; D′,E′
n=3/11), aberrant origin of the right subclavian artery (Ab-RSA; D′ n=3/11) and cer-
id; IA, inominate artery; LSA, left subclavian artery; LCC, left common carotid; AA, aortic
ary artery and aorta in healthy controls (F) and displays persistent truncus arteriosus in
controls (H, n=3) and Wnt1-cre;Dgcr8loxp/loxp mutants (I, n=3), the latter manifests
, pulmonary artery; RV, right ventricle; LV, left ventricle. Frontal view of E18.5 control
itioned, in a lateral situs in the thorax (K, n=3). LT, left thymic lobe; RT, right thymic
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(R26R-YFP) (Figs. 1A,B). Since DGCR8 was not detected at embryonic
day (E) 10.5 inWnt1-cre;Dgcr8loxp/loxp NC-descendants, that were rec-
ognized by activation of the R26R-YFP reporter, we conclude that Cre
mediated recombination efﬁciently disrupted the Dgcr8 gene
(Figs. 1A,B).
WhileWnt1-cre;Dgcr8loxp/+ and Dgcr8loxp/loxp mice were phenotypi-
cally normal and taken as controls throughout this study, Wnt1-cre;
Dgcr8loxp/loxp littermates died perinatally. Gross anatomical exploration
ofWnt1-cre;Dgcr8loxp/loxp mice revealed major cardiovascular defects at
E18.5, including PTA (100%), interrupted aortic arch (27%), cervical aor-
tic arch (18%) and aberrant origin of the right subclavian artery (27%)
(Figs. 1C–G). Coronal sections of dissectedWnt1-cre;Dgcr8loxp/loxp heartsA B
C D
E F
M
Fig. 2. Normal migration but reduced number of neural crest-descendants in Dgcr8mutant O
and Wnt1-cre;Dgcr8loxp/loxp mutant (B, n=8). 3, 3rd PAA; 4, 4th PAA; 6, 6th PAA. Whole mo
n=5 per genotype) on E10.5 Wnt1-cre;Dgcr8loxp/loxp embryos (D,F) and control littermates
Whole-mount beta-gal staining of E10.5 embryos, expressing a R26R-LacZ lineage tracing
Higher magniﬁcation reveals seemingly-normal cNCCs migration into the pharyngeal arch
black arrowhead denotes the distal-most LacZ-positive cells in the OFT. Sagittal sections of
ryngeal arch and the developing cardiac OFT, of control littermates (K) and Wnt1-cre;Dgcr8
sing R26R-LacZ, reveals reduced cNCC numbers at the OFT ofWnt1-cre;Dgcr8loxp/loxp mutants
pulmonary artery; PTA, persistent truncus arteriosus.further revealed a VSD (Figs. 1H,I). In addition we noted hypoplastic,
malpositioned thymi (Figs. 1J,K) and craniofacial abnormalities (Fig.
S1). This spectrum of defects is reminiscent of human cardiovascular
diseases, including manifestations described in DGS.
Initial pharyngeal arch artery formation is not disrupted in Dgcr8
mutants
To study potential early PAA patterning defects, we performed in-
tracardial ink injection on E10.5 embryos. The PAAs were well-
formed and patent in the majority of Wnt1-cre;Dgcr8loxp/loxp embryos
(n=7/8) and in all of their control littermates (n=24/24; Figs. 2A,B).
Therefore, ablation of Dgcr8 in cNCCs cells does not disrupt initial PAAG H
I J
K L
N
FT. India ink-injected E10.5 pharyngeal arch arteries. Lateral view of control (A, n=24)
unt in situ hybridization study of Ap2-alpha (C,D, n=5, per genotype), and Crabp1 (E,F,
(C,E). Arrows indicate the migratory streams of NCCs entering the pharyngeal arches.
reporter in control (G) and Wnt1-cre;Dgcr8loxp/loxp (H) embryos (n=4, per genotype).
es and OFT of controls (I) and Wnt1-cre;Dgcr8loxp/loxp (J). PA1, 1st pharyngeal arch. A
E10.5 embryos conﬁrm the presence of NC-derived, LacZ-positive cells, in the 1st pha-
loxp/loxp mutants (L). Whole-mount beta-gal staining of E12.5 embryonic hearts expres-
(N, n=4, denoted by a black arrowhead), relative to controls (M, n=3). Ao, aorta; PA,
AB
C
D
E
Fig. 3. Dgcr8mutant cNCC descendants exhibit normal proliferation and smooth muscle differentiation. Immunoﬂuorescent analysis of E10.5 sagittal sections reveals co-localization
of α-smooth muscle actin (SMA-α, red) and cNCC genetic fate tracer R26R-YFP (Green) in the OFT of control (A, n=3) andWnt1-cre;Dgcr8loxp/loxpmutant (B, n=3). Yellow, merged
green and red signals. Representative cells at the OFT, positive for SMA-α and for R26R-YFP, are denoted by white arrowheads in A and B, respectively. Transverse sections of E10.5
embryos at the level of the OFT reveals comparable levels of BrdU incorporation in E10.5 Wnt1-cre;Dgcr8loxp/loxp (D) relative to controls (C). Red, BrdU; Green, YFP; Blue, DAPI. (E)
Quantiﬁcation of the percentage of BrdU-positive cells out of the YFP-positive (cNCCs) in mutants (red) and controls (blue, n=4 per genotype). n.s. not statistically signiﬁcant.
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tions observed in Wnt1-cre;Dgcr8loxp/loxp embryos develop after
E10.5 and are likely related to the remodeling of the great vessels.Normal migration of cNCCs into the OFT region
cNCCs migrate in trajectories that pass through PAAs into the
cardiac OFT (Hutson and Kirby, 2007). To evaluate cNCC migration
we studied the expression of Crabp1 and Ap2-α, two NC markers.
At E10.5, the expression pattern of these markers was comparable
inWnt1-cre;Dgcr8loxp/loxp and control embryos (Figs. 2C–F), suggest-
ing normal NC migration into the PAAs and OFT. We have substanti-
ated our analysis of NC migration by genetic fate tracing, using
Wnt1-cre;Dgcr8loxp/loxp;R26R-LacZ embryos. At E10.5 we were able to
detect LacZ-positive Dgcr8loxp/loxp;Wnt1-cre;R26R-LacZ cNCC-descendants
on their path into the PAAs and the cardiac OFT, that were indistinguish-
able from controls (Figs. 2G-L). However, two days later, at E12.5, we
observed a signiﬁcant reduction in LacZ expression of Wnt1-cre;
Dgcr8loxp/loxp cNCC-descendants in the developing OFT, relative to
controls (Figs. 2M,N). cNCCs enter the heart in two parallel prongs
that are stereotypically positioned on opposite sides of the cardiac
OFT (Hutson and Kirby, 2007). In Wnt1-cre;Dgcr8loxp/loxp OFT, the
two prongs were malformed (Figs. 2M,N). Plausibly, perturbed OFT
morphogenesis was due to reduced cell numbers that ﬁrst manifests
between E10.5 and E12.5.Normal smooth muscle differentiation and proliferation of cNCCs in the
absence of Dgcr8.
Normal septum buildup and conotruncus remodeling requires
that cNCCs-descendants will differentiate into vascular smooth mus-
cle (Hutson and Kirby, 2007; Kirby et al., 1983). To evaluate the im-
pact of Dgcr8 ablation on cNCC differentiation into smooth muscle,
we immunostained sections of the cardiac OFT with α-smooth mus-
cle actin (SMA-α). This analysis revealed normal differentiation ca-
pacity of cNCCs into smooth muscle, even in the absence of Dgcr8
(Figs. 3A,B).
DGCR8 is a regulator of cell cycle (Wang et al., 2007), therefore we
hypothesized that the reduction in cNCC numbers observed in E12.5
Wnt1-cre;Dgcr8loxp/loxp OFTs could stem from impaired proliferation.
However, 5-bromo-2′-deoxyuridine (BrdU) incorporation analysis
revealed a comparable percentage of cNCC-descendants engaged in
mitotic cell cycle at E10.5, E11.5 and E12.5, in both Wnt1-cre;
Dgcr8loxp/loxp and controls (Figs. 3C-E and unpublished data). Thus,
the apparent decrease in cell numbers observed at E12.5 mutant
OFTs, is not due to inferior proliferation.
Inactivation of Dgrc8 in NCCs leads to elevated apoptosis
Loss of Dgcr8 was previously linked to enhanced apoptosis (Yi et
al., 2009), another potential reason for the disappearance of cNCCs
in the OFTs of E12.5 Wnt1-cre;Dgcr8loxp/loxp. Indeed, E10.5 Wnt1-cre;
A B
C D
E
F G H
I J K
Fig. 4. Dgcr8 mutant cNCC descendants exhibit enhanced cell death and attenuated ERK signaling. Cleaved caspase 3 (cCasp-3) immunoﬂuorescent analysis of E10.5 sagittal pha-
ryngeal arch (A,C) or outﬂow tract (OFT, B,D) sections. PA1-6 denote the 1st to the 6th pharyngeal arches, respectively; (n=3 per genotype). (E) Quantiﬁcation of cleaved caspase 3
(cCasp-3) immunoreactive cells reveals enhanced apoptosis in the pharyngeal arch region ofWnt1-cre;Dgcr8loxp/loxpmutant (red) relative to control (blue), but not in the OFT per-se.
* pb0.05. n.s. not statistically signiﬁcant. Immunoﬂuorescent analysis of E10.5 sagittal pharyngeal arch sections reveals signiﬁcant downregulation of phosphorylated Erk1/2 in
Wnt1-cre;Dgcr8loxp/loxp 1st and 2nd pharyngeal arches (I–K, J,K are enlargements of insets in I), relative to controls (F–H, G,H are enlarged micrographs of insets in F. n=3, per
genotype).
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ryngeal arches 1–4 and 6 (Figs. 4C,D), whilst control embryos exhib-
ited only limited, physiological apoptosis (Figs. 4A,B). Intriguingly,
apoptosis of cNCC descendants was not identiﬁed at the OFT region
(Figs. 4B,D,E), suggesting rather unexpectedly, that cNCCs cells are
susceptible to apoptosis at some positions along their journey but
that post-migration they can survive without DGCR8 activity. When
considered together, it appears that cNCCs normally migrate into
the OFT region until E10.5 but reduced total cell numbers hampers
normal morphogenesis of the aortic-pulmonary septum. This de-
crease in cell numbers is not due to inferior proliferation but because
many Dgcr8-null cNCCs undergo apoptosis at the caudal pharyngeal
arches, just before approaching the OFT region.
ERK signaling is attenuated in Dgcr8-null pharyngeal arches
In the pharyngeal arches, secreted FGF acts as a survival signal for
migratory cNCCs through activation of an intracellular ERK cascade. Dis-
ruption of FGF/ERK signaling gives rise to cardiovascular malformations
that are associated with DGS and are reminiscent of those observed in
Wnt1-cre;Dgcr8loxp/loxp mice (Frank et al., 2002; Krenz et al., 2008;
Newbern et al., 2008). Furthermore, loss ofmiRNA activity downstreamof Dicer attenuates ERK signaling in NCCs (Huang et al., 2010). There-
fore, we examined the expression level of phosphorylated Erk1/2 pro-
teins in Wnt1-cre;Dgcr8loxp/loxp embryos. Our confocal analysis
revealed signiﬁcantly decreased expression of phosphorylated Erk1/2
in E10.5Wnt1-cre;Dgcr8loxp/loxp pharyngeal arches (Figs. 4F–K), reminis-
cent of theDicer1-null phenotype and suggesting it as a likely contribut-
ing factor for apoptosis (Figs. 4F–K).
Taken together, our data provide in vivo evidence for Dgcr8 func-
tion in cardiovascular development and potentially associates Dgcr8,
which is positioned in humans on chromosome 22q11.2, to DGS.Discussion
Dgcr8 is annotated to the 22q11.2 microdeletion (Shiohama et al.,
2003) and Dgcr8 heterozygous disruption results in behavioral and
neuronal deﬁcits characteristic of DGS (Schoﬁeld et al., 2011; Stark
et al., 2008). In DGS, cardiovascular structures are frequently affected,
as a result of imperfect morphogenesis in embryonic stages (Ryan et
al., 1997), related to the contribution of cNCCs. In this work we used
mouse genetics to study how loss of Dgcr8 in NCCs impinges on car-
diovascular and pharyngeal development.
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of the OFT, since Wnt1-cre;Dgcr8loxp/loxp embryos develop with car-
diovascular defects reminiscent of those reported in humans, in-
cluding in DGS patients. Accordingly, Dgcr8 mutants fail to
remodel the conotruncus into independent aorta and pulmonary ar-
tery and exhibit VSD, interrupted aortic arch, and aberrant origin of
the right subclavian artery.
Genetic fate mapping revealed normal early cNCCs migration into
the OFT region at E10.5. However, many Dgcr8-null cNCCs undergo
apoptosis at the caudal pharyngeal arches, just before approaching
the OFT region. Thus, reduced total cell number hampers normal mor-
phogenesis of the aortic-pulmonary septum and the ventricular
septum.
FGF/ERK signaling provides essential survival cues for migratory
NCCs. Furthermore, apoptosis was reported in migratory cNCCs of
FGF hypomorphs, or when ERK was conditionally inactivated in
NCCs (Frank et al., 2002; Krenz et al., 2008; Newbern et al., 2008).
We therefore suggest that the necessity for Dgcr8-dependant FGF/
ERK survival cues is restricted to the pharyngeal region. Intriguingly,
cells that manage to inhabit the OFT, are protected from apoptosis,
even if Dgcr8 ceases to be expressed. This further supports the role
of FGF signaling in the Wnt1-cre;Dgcr8loxp/loxp model, since the ﬁeld
of FGF activity is deﬁned within the pharyngeal arches and does not
extend into the OFT, as revealed by the expression domains of FGF
downstream effectors, Pea3 and ERM (Chotteau-Lelievre et al.,
2001; Mesbah et al., 2008).
Dgcr8 effectors are very likely miRNA genes (Gregory et al., 2004;
Han et al., 2004). miRNA are involved in NCC migration, pharyngeal
arch development and smooth muscle differentiation (Cordes et al.,
2009; Small and Olson, 2011; Xin et al., 2009). For example, miR-
452 was recently shown to mediate non-cell-autonomous molecular
crosstalk between the Shh and FGF signaling pathways in the ﬁrst
pharyngeal arch (Sheehy et al., 2010). Similarly, miR-145 controls
NCC differentiation into smooth muscle upstream of SRF and Myocar-
din (Cordes et al., 2009). These speciﬁc miRNAs may be intriguing ef-
fectors of DGCR8, both in mouse models and in human pathology.
Interestingly, conditional inactivation of Dicer1 in NCCs by a
Wnt1-cre deleter caused OFT abnormalities that closely resemble
the defects reported here (Huang et al., 2010; Sheehy et al., 2010).
In addition, ERK signaling is attenuated in the Wnt1-cre;Dicer1
model, (Huang et al., 2010) suggesting that the regulation of FGF sig-
naling is likely mediated, intra-cellularly, by miRNAs in both mouse
models. These results strongly suggest that Dgcr8may work upstream
of Dicer1 in cNCC development. Nonetheless, and quite surprisingly,
in the Wnt1-cre;Dicer1 model, apoptosis was limited to the ﬁrst pha-
ryngeal arch but was not detected in the caudal pharyngeal arches or
the OFT (Huang et al., 2010). This difference maybe molecularly relat-
ed to DICER1 activity in other pathways including: siRNA, heterochro-
matin, and functional silencing of toxic Alu transcripts, (Kaneko et al.,
2011; Tam et al., 2008; Watanabe et al., 2008) which are independent
of DGCR8 and miRNAs.
In summary, our study characterizes the essential role of Dgcr8, a
Chr22q11.2 gene, in OFT morphogenesis and should motivate re-
search of mutations in the Dgcr8 gene or speciﬁc miRNA genes in
humans that manifest with cardiovascular defects.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2011.11.008.
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